Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
RLMD on Nasdaq
Paul Kelly - trading volume in the past year for Relmada Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
212K |
$550K |
$2.59 |
Sep 9, 2024 |
Direct |
|
|
| Stock Option (right to buy) |
65.7K |
|
|
May 24, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.